Dit medicijn versterkt de bijwerkingen van capecitabine, vooral op het bloed.
Others say that it might be too early for capecitabine to become standard treatment for those with cancer cells left after neoadjuvant chemotherapy.
Your doctor will do blood tests to monitor for this and adjust your dose of capecitabine or temporarily stop it if your blood counts are too low.
A total of 18 deaths due to all causes occurred either on study or within 28 days of receiving study drug 8 0. Talk to your specialist or advice line before you stop taking a cancer drug. It also helps to absorb capecitabine. Contact your doctor or nurse straight away if you ve been sick more than once in a day. Disease Sites 1-2 43 32 60 37 3-4 63 46 69 43 5 29 22 34 21 Dominant Site of Disease Visceral 101 75 110 68 Soft Tissue 30 22 35 22 Bone 4 3 17 10 Prior Chemotherapy Paclitaxel 135 100 162 100 Anthracycline 122 90 147 91 5-FU 110 81 133 82 Resistance to Paclitaxel 103 76 124 77 Resistance to an Anthracycline 55 41 67 41 Resistance to both Paclitaxel and an Anthracycline 43 32 51 31 Lung, pleura, liver, peritoneum Includes 2 patients treated with an anthracenedione.
Ask your doctor before use if you are taking the following medications:
The use of solid oral dosage forms of potassium chloride is contraindicated in patients taking glycopyrrolate oral solution.
Stopping the medication too soon may allow the bacteria to continue to grow, which may result in a return of the infection.
Increase dose to 5 mg orally once a day, with subsequent increases to 10 mg or 15 mg orally once a day if needed.
The increased risk of suicidal thoughts or behavior with AEDs was observed as early as one week after starting drug treatment with AEDs and persisted for the duration of treatment assessed.
Read the Patient Information Leaflet if available from your pharmacist before you start taking capecitabine and each time you get a refill. Capecitabine may cause dizziness, fatigue and nausea. DFCR was detected when perfusates were analyzed. Otherwise, call a poison control center right away.
Identify the main clinical indications for capecitabine therapy. Potential for predicting toxicity and response of fluoropyrimidines in patients.